Home › Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting
 

Keywords :   


Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting

2016-06-01 23:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview of the companys oncology program at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago on June 6, 2016 at 5:45 p.m. CDT (6:45 p.m. EDT). Language: English Contact: MerckMedia:Lainie Keller, (908) 236-5036orInvestor:Teri Loxam, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: hold meeting annual investor

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.10Nuclear plant 'will decimate fish stocks'
09.10Hurricane Milton Public Advisory Number 16A
09.10Summary for Hurricane Milton (AT4/AL142024)
09.10Eastern North Pacific Tropical Weather Outlook
09.10Atlantic Tropical Weather Outlook
09.10US says it may break up Google after landmark case
09.10Boeing withdraws 30% pay rise offer to striking staff
09.10Hurricane Milton Potential Storm Surge Flooding Map
More »